Kuopio

Finland

170 total trials 74 recruiting

Filter these 170 trials by phase, condition, sponsor and more.

Open in Search →

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan … Ended

2023-506487-13-00 5 Hormone receptor-positive, her2-negative advanced/metastatic breast ca
VEGF-D gene therapy in severe coronary artery disease. Phase II clinical trial (ReGenHeart). Ended

2024-512255-20-00 4 Clinical development and proof of principle testing of new regenerativ

Showing 169–170 of 170 trials